Movatterモバイル変換


[0]ホーム

URL:


CN1733156A - Trauma protecting paster containing aloe, its preparation process and application - Google Patents

Trauma protecting paster containing aloe, its preparation process and application
Download PDF

Info

Publication number
CN1733156A
CN1733156ACN 200410053653CN200410053653ACN1733156ACN 1733156 ACN1733156 ACN 1733156ACN 200410053653CN200410053653CN 200410053653CN 200410053653 ACN200410053653 ACN 200410053653ACN 1733156 ACN1733156 ACN 1733156A
Authority
CN
China
Prior art keywords
pharmaceutical composition
carbopol
aloe
polyacrylic resin
dry powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200410053653
Other languages
Chinese (zh)
Inventor
赵颖德
陈昭茂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority to CN 200410053653priorityCriticalpatent/CN1733156A/en
Publication of CN1733156ApublicationCriticalpatent/CN1733156A/en
Pendinglegal-statusCriticalCurrent

Links

Landscapes

Abstract

The invention provides a gel form medicinal composition, which mainly comprises 10-60% (W/V) of aloe diachyma freeze-dried powder, 0.05-2.0% (W/V) of silver sulfadiazine dried powder (antimicrobial agent), 0.1-5.0% (W/V) of Carbopol dried powder, and balancing excipient. The invention also relates to the process for preparing the pharmaceutical compositions. The invention further relates to the use of the pharmaceutical compositions in treating and nursing body surface wounds.

Description

Aloe wound dressing and its production and application
Technical field
The present invention relates to Aloe mesophyll lyophilized powder, polyacrylic resin (Carbopol) and silver sulfadiazine is that the external of characteristic component sticks type gel film Pharmaceutical composition, and its production and application.
Technical background
Aloe is traditional medical material of motherland's medical science, and in the world, Aloe has just had report to the therapeutical effect of skin wound from twentieth century since the eighties.The research of Rodrignez-Bigas and Visuthikosold etc. shows that all the wound surface epithelization of employing Aloe treatment early.But China mostly is limited to cosmetic field in the application facet of Aloe external, accidental Aloe is applied to the trial of wound repair, but mostly be oiliness cream or dehydration ointment form greatly, be unfavorable for daily minor trauma treatment and nursing, the Aloe Pharmaceutical composition that adopts advanced substrate and convenient route of administration is needed in the present technique field badly, to treat various daily slight body surface wounds and ulcer effectively.
The present invention selects the substrate of polyacrylic resin (Carbopol) as described Pharmaceutical composition for use, carboxyl in this polymer makes it have a series of characteristics that are applicable to the preparation Wound dressing, Giroux and Sehrenzel etc. have studied Carbopol Gel Transdermal performance and human body tolerance, carried out the interior medicine dynamics test simultaneously, the result shows nontoxic, the nonirritant of this material, does not influence the physiologically active of medicine.The Carbopol gel application has series of advantages such as stable performance, permeability is strong, the human body compliance is good in the preparation of Wound dressing, and the carrying medicament molecule very easily discharges by the micelle passage in the Carbopol gel structure simultaneously.
Beneficial effect
The present invention has broken the technical monopoly of imported product in this field, overcome traditional product that present daily trauma care uses to a certain extent easily and the technological deficiency of wound adhesion, filled up domestic blank, the development of product of the present invention helps the raising of the whole research and development technology of national natural plants, and can provide novel effectively product and method for daily slight Wound treating.
Summary of the invention
An object of the present invention is to provide with Aloe, polyacrylic resin (Carbopol) and silver sulfadiazine is the hydrophilic gel form membrane Pharmaceutical composition of curing on non-weaving cloth (base material) of characteristic component.
A further object of the present invention provides the preparation method of described Pharmaceutical composition.
Another object of the present invention provides described Pharmaceutical composition in the medicinal application for the treatment of and nursing daily body surface wound, ulcer and various other traumatic wound surface.
The objective of the invention is to implement: a kind of Pharmaceutical composition by following method, its characteristic component is the Aloe mesophyll lyophilized powder of 10-60% (W/V), the silver sulfadiazine dry powder (antibacterial) of 0.05-2.0% (W/V), polyacrylic resin (Carbopol) dry powder of 0.1-5.0% (W/V) and the excipient of surplus.
Described Pharmaceutical composition is for solidifying in 12g/m2-260g/m2Hydrophilic gel form membrane on the non-weaving cloth (base material).PH value is 6.5-7.5.
Below in conjunction with specific embodiment the present invention is done further elaboration.
Embodiment 1:
Preparation contains 10% (W/V) Aloe mesophyll lyophilized powder, the described Pharmaceutical composition of 0.1% (W/V) silver sulfadiazine 0.1% (W/V) polyacrylic resin.
Take by weighing the commercially available polyacrylic resin of 1g (Carbopol), add among the sterile distilled water 900mL, at room temperature swelling is after 4 hours, and restir 4 hours makes abundant dissolving.Add commercially available 1: 1 Aloe mesophyll lyophilized powder of 100mL in this solution, the commercially available silver sulfadiazine dry powder of 1g is 6.8 with the triethanolamine adjust pH after the even matter, obtains the milky gelinite.Evenly coat 16g/m then2On the non-weaving cloth, obtain gel film behind the dry solidification.
Embodiment 2:
Preparation contains 20% (W/V) Aloe mesophyll lyophilized powder, the described Pharmaceutical composition of 10% (W/V) sulfanilamide and 0.5% (W/V) polyacrylic resin.
Take by weighing the commercially available polyacrylic resin of 5g (Carbopol), add among the sterile distilled water 695mL, at room temperature swelling is after 4 hours, and restir 4 hours makes abundant dissolving.Add commercially available 1: 1 Aloe mesophyll lyophilized powder of 200mL in this solution, the commercially available sulfanilamide dry powder of 100g is 6.8 with the triethanolamine adjust pH after the even matter, obtains the milky gelinite.Evenly coat 28g/m then2On the non-weaving cloth, obtain gel film behind the dry solidification.
Embodiment 3:
Preparation contains 30% (W/V) Aloe mesophyll lyophilized powder, 0.1% (W/V) nitrofural, the described Pharmaceutical composition of 3.0% (W/V) polyacrylic resin.
Take by weighing the commercially available polyacrylic resin of 30g (Carbopol), add among the sterile distilled water 670mL, at room temperature swelling is after 4 hours, and restir 4 hours makes abundant dissolving.Add commercially available 1: 1 Aloe mesophyll lyophilized powder of 300mL in this solution, 1g nitrofural dry powder is 6.8 with the triethanolamine adjust pH after the even matter, obtains the milky gelinite.Evenly coat 35g/m then2On the non-weaving cloth, obtain gel film behind the dry solidification.
Embodiment 4:
Preparation contains 40% (W/V) Aloe mesophyll lyophilized powder, and 1.0% (W/V) neomycin and 2.0% (W/V) polyacrylic resin are stated Pharmaceutical composition
Take by weighing the commercially available polyacrylic resin of 20g (Carbopol), add among the sterile distilled water 570mL, at room temperature swelling is after 4 hours, and restir 4 hours makes abundant dissolving.Add commercially available 1: 1 Aloe mesophyll lyophilized powder of 400mL in this solution, 10g polygynax dry powder is 6.8 with the triethanolamine adjust pH after the even matter, obtains the milky gelinite.Evenly coat 45g/m then2On the non-weaving cloth, obtain gel film behind the dry solidification.
Embodiment 5:
Preparation contains 60% (W/V) Aloe mesophyll lyophilized powder, 3.0% (W/V) gentamycin, the described Pharmaceutical composition of 0.1% (W/V) polyacrylic resin.
Take by weighing the commercially available polyacrylic resin of 1g (Carbopol), add among the sterile distilled water 370mL, at room temperature swelling is after 4 hours, and restir 4 hours makes abundant dissolving.Add commercially available 1: 1 Aloe mesophyll lyophilized powder of 600mL in this solution, 30mL 80,000 IU gentamicin sulfate solution are 6.8 with the triethanolamine adjust pH after the even matter, obtain the milky gelinite.Evenly coat 120g/m then2On the non-weaving cloth, obtain gel film behind the dry solidification.
Embodiment 6:
Preparation contains 20% (W/V) Aloe mesophyll lyophilized powder, 1.0% (W/V) silver sulfadiazine, 3.0% (W/V) clotrimazole (Clotrimazole), the described Pharmaceutical composition of 5.0% (W/V) polyacrylic resin.
Take by weighing the commercially available polyacrylic resin of 50g (Carbopol), add among the sterile distilled water 710mL, at room temperature swelling is after 4 hours, and restir 4 hours makes abundant dissolving.In this solution, add commercially available 1: 1 Aloe mesophyll lyophilized powder of 200mL, the commercially available silver sulfadiazine dry powder of 10g, 30g clotrimazole (Clotrimazole) dry powder is 6.8 with the triethanolamine adjust pH after the even matter, obtains the milky gelinite.Evenly coat 260g/m then2On the non-weaving cloth, obtain gel film behind the dry solidification.

Claims (4)

CN 2004100536532004-08-122004-08-12Trauma protecting paster containing aloe, its preparation process and applicationPendingCN1733156A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN 200410053653CN1733156A (en)2004-08-122004-08-12Trauma protecting paster containing aloe, its preparation process and application

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN 200410053653CN1733156A (en)2004-08-122004-08-12Trauma protecting paster containing aloe, its preparation process and application

Publications (1)

Publication NumberPublication Date
CN1733156Atrue CN1733156A (en)2006-02-15

Family

ID=36075911

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN 200410053653PendingCN1733156A (en)2004-08-122004-08-12Trauma protecting paster containing aloe, its preparation process and application

Country Status (1)

CountryLink
CN (1)CN1733156A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN103055107A (en)*2013-02-062013-04-24贺军Aloe wound paste and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN103055107A (en)*2013-02-062013-04-24贺军Aloe wound paste and preparation method thereof

Similar Documents

PublicationPublication DateTitle
EP2253665B1 (en)Freeze-dried composition
Pedram Rad et al.Preparation and characterization of Calendula officinalis-loaded PCL/gum arabic nanocomposite scaffolds for wound healing applications
DE3650776T2 (en) Polysaccharide esters and their salts
CA2002404A1 (en)Delivery system for pharmaceutical or therapeutic actives
Asati et al.Bioadhesive or mucoadhesive drug delivery system: a potential alternative to conventional therapy
US7998379B2 (en)Process for the production of porous moulded articles containing alginate
RU2326137C2 (en)Method of obtaining porous moulded articles containing alginate
JP2002521392A (en) Glucuronoglucan polymer complex
CN104258456B (en)A kind of wound repair gel containing hexagonal mesoporous silicon and preparation method thereof
EP0804245A1 (en)Collagen preparation for the controlled release of active substances
CN111012803B (en) Biomaterial devices and topical compositions for guided tissue regeneration
CN108210689A (en)A kind of canker sore film containing hyaluronic acid and preparation method thereof
CN115025385A (en) A kind of microneedle patch with differential rapid drug release and its preparation method and application
Ding et al.Research progress and challenges of composite wound dressings containing plant extracts
CN115006337B (en)Double-layer hydrophilic gel patch for repairing skin wound surface and preparation method thereof
CN110624103B (en) Biomaterial devices and topical compositions for treating skin abnormalities
CN104740141B (en)A kind of antimicrobial spray and preparation method thereof
KR101576244B1 (en)aloin loaded wound dressing composition based on hydrogel and manufacturing method thereof
Jose et al.Herbal extracts based scaffolds for wound healing therapy
CN1733156A (en)Trauma protecting paster containing aloe, its preparation process and application
CN117224731A (en)Bionic medical tissue adhesive and preparation method thereof
CN1679643A (en)Aloe trauma curing gel, preparation and use thereof
CN108452211A (en)A kind of compound chitosan renovation agent
CN119174839B (en) Skin repair liquid dressing and preparation method and application thereof
CN117695222B (en)Artemisinin azelate-polyethylene glycol diamine micelle for improving skin problems and preparation method thereof

Legal Events

DateCodeTitleDescription
C06Publication
PB01Publication
C10Entry into substantive examination
SE01Entry into force of request for substantive examination
C02Deemed withdrawal of patent application after publication (patent law 2001)
WD01Invention patent application deemed withdrawn after publication

[8]ページ先頭

©2009-2025 Movatter.jp